Executive Order 2020-20 was rescinded by the Governor's Office effective July 9, 2021. COVID-19 FAQs have been updated to reflect this information.
COVID-19 FAQs updated April 20, 2022 (as situations progress, the FAQ will continue to change and be revised). Please check the ASBP website for updates.
August 23, 2022: At its meeting on August 10, 2022, the Board supported the FDA's Emergency Use Authorization for Pharmacists to prescribe Paxlovid. The Board emphasized exercising professional judgement with respect to implementation, including careful clinical evaluation, documentation, and adequate staffing. The Board's discussion of this matter may be viewed here: https://youtu.be/kK_4T0ytqY8?list=PLgYyFEY5yB1krn6ggQB2NZdSbvCWdvHm_&t=30382
Have a question about COVID-19? Submit your question here.
COVID-19 HOTLINE (FOR PATIENTS AND HEALTHCARE PROVIDERS): 1-844-542-8201
Arizona Department of Health (ADHS)
ADHS's Guidance for Healthcare Providers & Long-term Care Facilities
U.S.Centers for Disease Control and Prevention (CDC)
Tenth Amendment to Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID–19
Guidance for Licensed Pharmacists, COVID-19 Testing, and Immunity under the PREP Act (04/08/2020)
Guidance for Licensed Pharmacists and Pharmacy Interns Regarding COVID-19 Vaccines and Immunity under the PREP Act (09/03/2020)
Guidance for PREP Act Coverage for Qualified Pharmacy Technicians and State-Authorized Pharmacy Interns for Childhood Vaccines, COVID-19 Vaccines, and COVID-19 Testing (10/20/2020)
Operational Considerations for Sterile Compounding During COVID-19 Pandemic
USP COVID-19 Vaccine Handling Toolkit
CDC’s Interim Guidance on preventing COVID-19 from spreading, which includes Strategies for Optimizing the Supply of N95 Respirators
Healthcare Supply of Personal Protective Equipment
FDA’s Surgical Mask and Gown Conservation Strategies - Letter to Healthcare Providers